Market research
603566.SHG Pulike Biological Engineering, Inc
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4B
- P/E ratio
- 24.49
- Analyst target
- 14
- Dividend yield
- 5.6%
- Beta
- 0.29
Community
Investor discussion
1 comment
Sign in to join the 603566.SHG discussion.
5 years, 5 months ago
Pulike Biological Engineering, Inc is currently in a long term uptrend where the price is trading 5.0% above its 200 day moving average.
From a valuation standpoint, the stock is 28.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.9.
Pulike Biological Engineering, Inc's total revenue rose by 46.2% to $281M since the same quarter in the previous year.
Its net income has increased by 296.3% to $56M since the same quarter in the previous year.
Finally, its free cash flow grew by 81.3% to $82M since the same quarter in the previous year.
Based on the above factors, Pulike Biological Engineering, Inc gets an overall score of 5/5.